- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/14 - Antivirals for RNA viruses
Patent holdings for IPC class A61P 31/14
Total number of patents in this class: 12081
10-year publication summary
|
170
|
185
|
271
|
380
|
409
|
1790
|
1958
|
2208
|
1374
|
522
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2032 |
127 |
| The Regents of the University of California | 19868 |
95 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2845 |
95 |
| Bristol-myers Squibb Company | 4878 |
84 |
| Centre National de La Recherche Scientifique | 10414 |
76 |
| Katholieke Universiteit Leuven | 1187 |
69 |
| Janssen Pharmaceuticals, Inc. | 431 |
66 |
| Enanta Pharmaceuticals, Inc. | 428 |
65 |
| Modernatx, Inc. | 1256 |
65 |
| Emory University | 1624 |
63 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
57 |
| The Trustees of the University of Pennsylvania | 4314 |
51 |
| BioNTech SE | 657 |
50 |
| Vanderbilt University | 1894 |
49 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
47 |
| Board of Regents, The University of Texas System | 5772 |
46 |
| The Board of Trustees of the Leland Stanford Junior University | 6402 |
45 |
| Pfizer Inc. | 3379 |
43 |
| Institut Pasteur | 785 |
43 |
| The Wistar Institute of Anatomy and Biology | 448 |
43 |
| Other owners | 10802 |